Unknown

Dataset Information

0

Diabetes and dyslipidemia: characterizing lipoprotein metabolism.


ABSTRACT: Premature atherosclerosis in diabetes accounts for much of the decreased life span. New treatments have reduced this risk considerably. This review explores the relationship among the disturbances in glucose, lipid, and bile salt metabolic pathways that occur in diabetes. In particular, excess nutrient intake and starvation have major metabolic effects, which have allowed us new insights into the disturbance that occurs in diabetes. Metabolic regulators such as the forkhead transcription factors, the farnesyl X transcription factors, and the fibroblast growth factors have become important players in our understanding of the dysregulation of metabolism in diabetes and overnutrition. The disturbed regulation of lipoprotein metabolism in both the intestine and the liver has been more clearly defined over the past few years, and the atherogenicity of the triglyceride-rich lipoproteins, and - in tandem - low levels of high-density lipoproteins, is seen now as very important. New information on the apolipoproteins that control lipoprotein lipase activity has been obtained. This is an exciting time in the battle to defeat diabetic atherosclerosis.

PROVIDER: S-EPMC5546776 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC4115215 | BioStudies
| S-EPMC6482102 | BioStudies
| S-EPMC8301479 | BioStudies
2019-01-01 | S-EPMC6668417 | BioStudies
| S-EPMC3086062 | BioStudies
| S-EPMC2822716 | BioStudies
| S-EPMC5601316 | BioStudies
| S-EPMC4561042 | BioStudies
| S-EPMC6202200 | BioStudies
| S-EPMC8393881 | BioStudies